ID: MRFR/HC/7002-HCR | 110 Pages | Published By Rahul Gotadki on March 2023
The Celiac Disease Treatment Market is anticipated to have a significant growth with a 11.03% CAGR. Therefore, the market value will further increase up to USD 1,061.20 Million in the studied forecast period 2020-2030. Celiac disease is basically an auto-immune and genetic disorder. This disease damages the small intestine and causes various diseases such as neurological disorders, low bone density, infertility, and even cancers.
Several factors such as the penetration of therapeutic products among developing countries are empowering the Celiac Disease Treatment Market Growth. However, the growing awareness for healthcare and technological advancements will improve the market growth in this region. It is anticipated that the Asia-Pacific region will rise to significant CAGR during the studied forecast period.
Governments across the world were highly affected due to the outbreak of the COVID-19 disease. It put a huge burden on the healthcare sector to treat the affected patients. Due to this reason, treatment of other diseases was highly affected. However, the development of vaccines and waiver of lockdown has helped the market to improve its growth. Along with that, the market players are investing to improve Celiac Disease Treatment Market Growth in the future years.
Various drivers such as the rising use of therapeutic drugs, diseases like diabetes, and favorable policies by governments will boost the market. Additionally, the prevalence of junk and packaged foods, rising disposable income will further drive the Celiac Disease Treatment Market in the future years.
The low availability of specialized treatment across various underdeveloped and developing countries can restraint the market growth. Also, low awareness and lack of skilled professionals for diagnosis can hamper the market growth significantly.
Various opportunities such as investments by the key players can offer new opportunities for the market. Acquisitions, collaborations, mergers, partnerships, etc. are anticipated to open new opportunities for the Celiac Disease Treatment Market.
As of now, there is still no drug available for the treatment of celiac disease. Along with that, the misdiagnosis of the treatment can be a major challenge for the Celiac Disease Treatment Market Growth.
The Compound Annual Growth Rate (CAGR) of the Celiac Disease Treatment Market is estimated to touch 12%. Therefore, the market value will further increase up to USD 680.5 Million in the studied forecast period 2021-2028. The rising technological developments and improvement in the treatment of the disease will have a significant impact on the market.
Value Chain Analysis
The Celiac Disease Treatment Market Analysis suggests that the market will grow significantly in the upcoming years. The rising developments and several drivers such as increasing cases of diabetes and other neurological diseases will further increase the Celiac Disease Treatment Market Trends. Therefore, the value chain will improve in the forthcoming years.
The Celiac Disease Treatment Market Size is divided into various segments such as treatment, drugs, enzyme type, and end-user. On the basis of treatment, the market is fragmented into Immunosuppressive Drugs and Steroids, Therapeutic Vaccines, and Dietary and Vitamin Supplements.
On the basis of drugs, the Celiac Disease Treatment Market is segmented into Second-Line Treatment and First-Line Treatment.
On the basis of enzyme type, the Market is bifurcated into Gas, Bloating, Fatigue, Diarrhoea, Distension, and Others.
On the basis of end-user, the Market is segmented into Clinical Research Organisations, Clinics, and Hospitals, and Academic Institutes.
Regionally, the Celiac Disease Treatment Market Size is divided into Europe, Americas, Africa, and the Middle East, and Asia-Pacific. The Americas is expected to hold the largest share in the upcoming years. The rising cases of celiac diseases are one of the celiac diseases and the presence of various key players among the countries is pushing the market growth.
Secondly, Europe will have the second-largest Celiac Disease Treatment Market Share in the upcoming years. The increasing expenditure in the healthcare and presence of advanced healthcare infrastructure is evaluated to improve the market growth in the upcoming years.
Asia-Pacific region is anticipated to record the fastest growth in the future years. Mainly countries such as India, China are developing at a rapid speed. As a result, the market will have significant growth in the future years.
Africa and the Middle East region are evaluated to have the least share in the Celiac Disease Treatment Market. Hence, various underdeveloped nations and low infrastructure are the major cause of the slow growth rate.
The Celiac Disease Treatment Market is fragmented with the presence of various key players. These key players play a crucial role in elevating market growth. They do strategic developments such as acquisitions, partnerships, collaborations, new ventures, etc. Some of the key players in the market are as follows.
No recent developments were found.
The overview of the Celiac Disease Treatment Market Outlook is listed below.
Report Score and Segmentation
The report score of the Celiac Disease Treatment Market Forecast is to highlight information such as market CAGR value, opportunities, drivers, key players, recent development, etc. Furthermore, the information provided in this report is collected from various secondary and primary sources.
By Enzyme Type
|Market Size||USD 1061.20 Million|
|Forecast Units||Value (USD Million)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Treatment and End-User|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Amgen Inc. (US), Amneal Pharmaceuticals LLC (US), BioLineRx (Israel), Calypso Biotech SA (Switzerland), Freedom Foods Group Limited (Australia), General Mills, Inc. (US), Glenmark Pharmaceuticals Inc. (India), Hain Celestial Group, Inc. (US), Innovate Biopharmaceuticals Inc. (US), Kellogg Company (US), Mondelez International Inc. (US), Mylan Pharmaceuticals Inc. (US), Pinnacle Foods, Inc. (US), Selecta Biosciences, Inc (US), Takeda Pharmaceutical Company Ltd (Japan), The Kraft Heinz Company (US), West-Ward Pharmaceutical (US), Zedira GmbH (Germany), Zydus Pharmaceuticals Inc. (US)|
|Key Market Opportunities||Technology advances and research and development|
|Key Market Drivers||
Celiac Disease Treatment Market is projected to grow at an 11.03% CAGR between 2020-2030.
The Americas is expected to dominate the Celiac Disease Treatment Market.
Celiac Disease Treatment Market is predicted to touch USD 1061.20 million by 2030.
Hospitals and clinics will lead the Celiac Disease Treatment Market.
Gluten-free diet segment will dominate the Celiac Disease Treatment Market.